Products | Focused Ultrasound Therapy | August 07, 2015

TULSA-PRO

TULSA-PRO

Related Content

FDA Approves IDE Application to Initiate Trial for Treating Locally Recurrent Prostate Cancer
News | FDA
FDA Approves IDE Application to Initiate Trial for Treating Locally Recurrent Prostate Cancer

Dec. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT, has announced ...

Time December 04, 2025
arrow
EDAP Secures FDA Clearance for HIFU System's Latest Enhancements
News | Ultrasound Imaging
EDAP Secures FDA Clearance for HIFU System's Latest Enhancements

Nov 20, 2025 - EDAP TMS SA has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance ...

Time November 21, 2025
arrow
FAU Debuts 'Bench-to-Bedside' MRI, Focused Ultrasound Platform to Accelerate Research, Treatment of Neurological Disorders
News | Magnetic Resonance Imaging (MRI)
FAU Debuts 'Bench-to-Bedside' MRI, Focused Ultrasound Platform to Accelerate Research, Treatment of Neurological Disorders

Oct. 14, 2025 — Florida Atlantic University has expanded its NeuroInnovate Center, becoming the first institution ...

Time October 14, 2025
arrow
Multimodal AI Shows No Evidence of Bias in Prostate Cancer Study
Feature
Multimodal AI Shows No Evidence of Bias in Prostate Cancer Study

A new study published in JCO Clinical Cancer Informatics tackles a critical challenge in cancer diagnostics: ensuring ...

Time July 01, 2025
arrow
Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) has accepted the filing of its New Drug Application (NDA) for TLX007-CDx
News | Radiopharmaceuticals and Tracers
FDA Accepts Telix NDA for New Prostate Cancer Imaging Agent

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
Avenda Health’s study, published in The Journal of Urology, solidifies the power of AI in oncology as a viable and accurate diagnostic tool
News | Artificial Intelligence
New Study Proves AI Enhances Physicians’ Ability to Identify Extent of Prostate Cancer with 84 Percent Accuracy

June 17, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care ...

Time June 17, 2024
arrow
Latest innovations in clinical cancer research discussed at American Society of Clinical Oncology (ASCO) Annual Meeting
News | Radiopharmaceuticals and Tracers
Shine Technologies Partners with Blue Earth Therapeutics for First Supply of Ilumira from Its New Facility

June 7, 2024 — Shine Technologies, LLC, a pioneer in next-generation fusion-based technology, today announced a new ...

Time June 07, 2024
arrow
new 3-part video series on advancements in diagnostic radiology with Robert L. Bard, MD, PC, DABR, FASLMS
Feature | Radiation Oncology | By Melinda Taschetta-Millane
Advancements in Diagnostic Radiology Video Series with Robert L. Bard, MD, PC, DABR, FASLMS

In a new 3-part video series on advancements in diagnostic radiology with Robert L. Bard, MD, PC, DABR, FASLMS ...

Time April 10, 2024
arrow
For the first time in a commercial setting, physicians are able to see the extent of disease and provide more personalized and precise treatments for prostate cancer patients using AI
News | Artificial Intelligence
Avenda Health Announces First Commercial Use of Unfold AI on Prostate Cancer Patients in the US

March 21, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care ...

Time March 21, 2024
arrow
Videos | Radiation Oncology
VIDEO: Advancements and New Technology in Diagnostic Radiology to Help in the Fight Against Cancer

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now